Showing 1 - 10 of 916
We analyze whether the possibility for physicians to dispense drugs increases health care expenditures due to the incentives created by the markup on drugs sold. Using comprehensive physician-level data from Switzerland, we exploit the fact that there is regional variation in the dispensing...
Persistent link: https://www.econbiz.de/10009772799
We analyze changes in the willingness to substitute from prescribed pharmaceuticals to more affordable generic equivalents in response to the first experience with a substitution. Using Swedish individual-level data of prescribed and dispensed pharmaceuticals, we employ a dynamic event study and...
Persistent link: https://www.econbiz.de/10013175464
Persistent link: https://www.econbiz.de/10009616651
Persistent link: https://www.econbiz.de/10001252057
Persistent link: https://www.econbiz.de/10001252058
Persistent link: https://www.econbiz.de/10001232008
Biomedical R&D Price Index (BRDPI) focused on input costs rose only 2.2-fold. Most of the disparity appears to be attributable to … agencies to develop a producer price index for this type of R&D activity, contributing to broader efforts to develop a deflator …
Persistent link: https://www.econbiz.de/10013064303
The prescription drug component of the Consumer Price Index (CPI measures recent and past drug price changes, and …
Persistent link: https://www.econbiz.de/10012929587
The prescription drug component of the Consumer Price Index (CPI measures recent and past drug price changes, and …
Persistent link: https://www.econbiz.de/10012453503
Biomedical R&D Price Index (BRDPI) focused on input costs rose only 2.2-fold. Most of the disparity appears to be attributable to … agencies to develop a producer price index for this type of R&D activity, contributing to broader efforts to develop a deflator …
Persistent link: https://www.econbiz.de/10012459743